US › Healthcare

Mangoceuticals, Inc. Common Stock (MGRX)

US · Healthcare · Health Information Services

$0.19+1.62%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$68,757

Revenue YoY

-59.1%

Net profit

$-1.3M

EPS

$-0.09

Net margin

-1,909.1%

Key statistics

Market cap

$4.3M

Forward P/E

0.0

P/B

0.38

Book value

$0.69

EPS (TTM)

$-0.93

52-week high

$2.41

52-week low

$0.16

50-day MA

$0.37

200-day MA

$0.40

Beta

2.15

Shareholding

Insiders

17.61%

Institutions

5.51%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.53%
XTX Topco Ltd	0.84%
Geode Capital Management, LLC	0.70%
Ikarian Capital, LLC	0.62%
Vanguard Capital Management, LLC	0.55%
Vanguard Fiduciary Trust Co	0.26%
BOOTHBAY FUND MANAGEMENT, LLC	0.17%
Northern Trust Corp	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Mangoceuticals, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.